Literature DB >> 23945275

Expanding the therapeutic frontier in atherosclerosis.

Amy S Major1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23945275      PMCID： PMC3902169          DOI： 10.1097/FJC.0b013e3182a18bea

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN： 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  18 in total

Review 1.  Atherosclerosis. the road ahead.

Authors:  C K Glass; J L Witztum
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.

Authors:  Sander I van Leuven; Yanice V Mendez-Fernandez; Ashley J Wilhelm; Nekeithia S Wade; Curtis L Gabriel; John J Kastelein; Erik S Stroes; Paul P Tak; Amy S Major
Journal:  Ann Rheum Dis       Date:  2011-09-27       Impact factor: 19.103

Review 3.  Current concept of reverse cholesterol transport and novel strategy for atheroprotection.

Authors:  Koh Ono
Journal:  J Cardiol       Date:  2012-10-12       Impact factor: 3.159

4.  HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.

Authors:  Jonathan E Feig; James X Rong; Raanan Shamir; Marie Sanson; Yuliya Vengrenyuk; Jianhua Liu; Katey Rayner; Kathryn Moore; Michael Garabedian; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

5.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

6.  Lupus Atherosclerosis Prevention Study (LAPS).

Authors:  M A Petri; A N Kiani; W Post; L Christopher-Stine; L S Magder
Journal:  Ann Rheum Dis       Date:  2010-12-21       Impact factor: 19.103

Review 7.  Statin therapy in lupus-mediated atherogenesis: two birds with one stone?

Authors:  Sander I van Leuven; Yanice V Mendez-Fernandez; Erik S Stroes; Paul P Tak; Amy S Major
Journal:  Ann Rheum Dis       Date:  2010-11-10       Impact factor: 19.103

8.  Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.

Authors:  Jaime Llodrá; Véronique Angeli; Jianhua Liu; Eugene Trogan; Edward A Fisher; Gwendalyn J Randolph
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

9.  Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.

Authors:  Maureen McMahon; Jennifer Grossman; Brian Skaggs; John Fitzgerald; Lori Sahakian; Nagesh Ragavendra; Christina Charles-Schoeman; Karol Watson; Weng Kee Wong; Elizabeth Volkmann; Weiling Chen; Alan Gorn; George Karpouzas; Michael Weisman; Daniel J Wallace; Bevra H Hahn
Journal:  Arthritis Rheum       Date:  2009-08

10.  High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids.

Authors:  Maureen McMahon; Brian J Skaggs; Lori Sahakian; Jennifer Grossman; John FitzGerald; Nagesh Ragavendra; Christina Charles-Schoeman; Marissa Chernishof; Alan Gorn; Joseph L Witztum; Weng Kee Wong; Michael Weisman; Daniel J Wallace; Antonio La Cava; Bevra H Hahn
Journal:  Ann Rheum Dis       Date:  2011-06-13       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.